We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
376
DELISTED
Signature Bank
SBNY
| $850K | 0.09% |
6,636
+2,658
| +67% | +$338K |
|
377
Texas Instruments
TXN
$257B
| $847K | 0.09% |
+7,983
| New | +$827K |
|
378
HP
HPQ
$26B
| $846K | 0.09% |
43,533
-78,557
| -64% | -$1.66M |
|
379
Trex
TREX
$4.89B
| $844K | 0.09% |
+27,428
| New | +$958K |
|
380
Helen of Troy
HELE
$676M
| $842K | 0.09% |
7,265
+3,998
| +122% | +$461K |
|
381
Cooper Companies
COO
$14.4B
| $841K | 0.09% |
+11,356
| New | +$792K |
|
|
TCF
382
DELISTED
TCF Financial Corporation Common Stock
TCF
| $839K | 0.09% |
20,375
+14,562
| +251% | +$630K |
|
383
MasterCraft Boat Holdings
MCFT
$595M
| $838K | 0.08% |
37,118
+3,095
| +9% | +$68.5K |
|
|
PINC
384
DELISTED
Premier
PINC
| $838K | 0.08% |
24,300
-19,857
| -45% | -$734K |
|
385
CBRE Group
CBRE
$42.5B
| $834K | 0.08% |
+16,856
| New | +$791K |
|
386
Enova International
ENVA
$6.46B
| $834K | 0.08% |
36,534
+4,837
| +15% | +$114K |
|
387
Transocean
RIG
$5.84B
| $832K | 0.08% |
95,479
-10,029
| -10% | -$85.9K |
|
|
BID
388
DELISTED
Sotheby's
BID
| $832K | 0.08% |
+22,035
| New | +$883K |
|
389
Portland General Electric
POR
$5.75B
| $830K | 0.08% |
16,002
+4,907
| +44% | +$239K |
|
390
Simmons First National
SFNC
$3.41B
| $827K | 0.08% |
+33,800
| New | +$867K |
|
|
KRA
391
DELISTED
Kraton Corporation
KRA
| $826K | 0.08% |
+25,657
| New | +$773K |
|
392
Standard BioTools
LAB
$305M
| $823K | 0.08% |
+61,910
| New | +$653K |
|
393
SITE Centers
SITC
$164M
| $823K | 0.08% |
+77,468
| New | +$783K |
|
394
Sportsman's Warehouse
SPWH
$47.2M
| $822K | 0.08% |
171,278
-47,018
| -22% | -$253K |
|
|
HMHC
395
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $822K | 0.08% |
+113,096
| New | +$1.02M |
|
396
Ares Capital
ARCC
$14.1B
| $821K | 0.08% |
+47,911
| New | +$803K |
|
397
WD-40
WDFC
$3.1B
| $821K | 0.08% |
+4,843
| New | +$853K |
|
|
CSII
398
DELISTED
Cardiovascular Systems, Inc.
CSII
| $820K | 0.08% |
+21,219
| New | +$719K |
|
399
Methode Electronics
MEI
$592M
| $818K | 0.08% |
28,429
+11,570
| +69% | +$316K |
|
400
Cato Corp
CATO
$65.5M
| $816K | 0.08% |
54,500
-600
| -1% | -$8.87K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.